hrcak mascot   Srce   HID

Original scientific paper

Quality of Cardiovascular Drugs Prescribing in Croatia 2003–2008

Danijela Štimac

Fulltext: english, pdf (74 KB) pages 189-194 downloads: 474* cite
APA 6th Edition
Štimac, D. (2012). Quality of Cardiovascular Drugs Prescribing in Croatia 2003–2008. Collegium antropologicum, 36 supplement 1 (1), 189-194. Retrieved from https://hrcak.srce.hr/75672
MLA 8th Edition
Štimac, Danijela. "Quality of Cardiovascular Drugs Prescribing in Croatia 2003–2008." Collegium antropologicum, vol. 36 supplement 1, no. 1, 2012, pp. 189-194. https://hrcak.srce.hr/75672. Accessed 20 Oct. 2020.
Chicago 17th Edition
Štimac, Danijela. "Quality of Cardiovascular Drugs Prescribing in Croatia 2003–2008." Collegium antropologicum 36 supplement 1, no. 1 (2012): 189-194. https://hrcak.srce.hr/75672
Harvard
Štimac, D. (2012). 'Quality of Cardiovascular Drugs Prescribing in Croatia 2003–2008', Collegium antropologicum, 36 supplement 1(1), pp. 189-194. Available at: https://hrcak.srce.hr/75672 (Accessed 20 October 2020)
Vancouver
Štimac D. Quality of Cardiovascular Drugs Prescribing in Croatia 2003–2008. Collegium antropologicum [Internet]. 2012 [cited 2020 October 20];36 supplement 1(1):189-194. Available from: https://hrcak.srce.hr/75672
IEEE
D. Štimac, "Quality of Cardiovascular Drugs Prescribing in Croatia 2003–2008", Collegium antropologicum, vol.36 supplement 1, no. 1, pp. 189-194, 2012. [Online]. Available: https://hrcak.srce.hr/75672. [Accessed: 20 October 2020]

Abstracts
The aim of the study was to determine cardiovascular drugs utilization and quality of prescribing in Croatia from 2003 to 2008. Data on the outpatient utilization of cardiovascular drugs in Croatia were collected during 2003–2008. Data on the size and number of packages, were obtained from Croatian institute for Health Insurance (CIHI). Based on the data obtained, the numbers of DDD and DDD per 1000 inhabitants per day (DDD/1000/day) were calculated for all
cardiovascular drugs. Quality of drugs prescribing was assessing using Drug Utilization 90% (DU90%) method. Renin-angiotensin system agents showed highest share in the utilization of group C drugs, followed by calcium channel blockers. These two groups of drugs accounted for half of the overall cardiovascular drug utilization. Greatest changes were observed in the groups of renin-angiotensin system agents and hypolipemics. The number of drugs within DU90% segment increased between 2003 and 2008. In the same period Cost/DDD decreased.

Keywords
cardiovascular; drugs; prescribing; ATC/DDD methodology; Croatia

Hrčak ID: 75672

URI
https://hrcak.srce.hr/75672

Visits: 670 *